RT @NicholasShortMD: Our paper on aza + ven +gilteritinib for FLT3mut #AML now online at @JCO_ASCO In frontline FLT3mut AML, CR 90% (vs. 30…
So far, Altmetric has seen
150 X posts from 124 X users, with an upper bound of 1,010,109 followers.
22 followers
3,219 followers
RT @syed_abutalibmd: Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML | Journal of…
445 followers
RT @syed_abutalibmd: Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML | Journal of…
1,384 followers
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML | Journal of Clinical Oncology https://t.co/3cGZLdOzR2